Precigen (PGEN) Current Leases (2012 - 2026)
Precigen (PGEN) posted quarterly Current Leases of $1.1 million for Q1 2026, up 15.09% year-over-year from $928000.0 in Q1 2025, and down 5.99% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Precigen (PGEN) Current Leases (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Current Leases for 10 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 15.09% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 15.09% YoY), while the FY2025 annual figure was $1.1 million, up 18.83% from the prior year.
- Current Leases fell to $1.1 million in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Current Leases topped out at $1.6 million in Q1 2022 and bottomed at $928000.0 in Q1 2025.
- Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2022 — Current Leases sank 46.86% — and 2023, when it surged 37.56%.
- Precigen's Current Leases stood at $1.2 million in 2022, then fell by 0.58% to $1.2 million in 2023, then fell by 20.47% to $956000.0 in 2024, then grew by 18.83% to $1.1 million in 2025, then dropped by 5.99% to $1.1 million in 2026.
- Business Quant data shows PGEN's Current Leases at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 1.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 930,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 956,000.00 |
| Sep 30, 2024 | 988,000.00 |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.96 Mn |